Literature DB >> 18325916

Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?

S Bahri, J-H Chen, H J Yu, A Kuzucan, O Nalcioglu, M-Y Su.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18325916      PMCID： PMC2613186          DOI： 10.1093/annonc/mdn043

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  13 in total

1.  MRI features of breast cancer: a correlation study with HER-2 receptor.

Authors:  G Agrawal; J H Chen; H M Baek; D Hsiang; R S Mehta; O Nalcioglu; M-Y Su
Journal:  Ann Oncol       Date:  2007-11       Impact factor: 32.976

Review 2.  Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.

Authors:  P S Tofts
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

3.  A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX.

Authors:  Virginia Kaklamani
Journal:  Expert Rev Mol Diagn       Date:  2006-11       Impact factor: 5.225

4.  Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.

Authors:  P C Stomper; S Herman; D L Klippenstein; J S Winston; S B Edge; M A Arredondo; R V Mazurchuk; L E Blumenson
Journal:  Radiology       Date:  1995-11       Impact factor: 11.105

5.  Dynamic magnetic resonance imaging in determining histopathological prognostic factors of invasive breast cancers.

Authors:  Nermin Tuncbilek; Hakki Muammer Karakas; Ozerk Omur Okten
Journal:  Eur J Radiol       Date:  2005-02       Impact factor: 3.528

6.  Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue.

Authors:  Lida Mina; Sharon E Soule; Sunil Badve; Fredrick L Baehner; Joffre Baker; Maureen Cronin; Drew Watson; Mei-Lan Liu; George W Sledge; Steve Shak; Kathy D Miller
Journal:  Breast Cancer Res Treat       Date:  2006-10-13       Impact factor: 4.872

7.  Prognostic value of contrast-enhanced MR mammography in patients with breast cancer.

Authors:  U Fischer; L Kopka; U Brinck; M Korabiowska; A Schauer; E Grabbe
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 8.  Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.

Authors:  Elizabeth Dobbe; Kristen Gurney; Sara Kiekow; Jeffery S Lafferty; Jill M Kolesar
Journal:  Am J Health Syst Pharm       Date:  2008-01-01       Impact factor: 2.637

9.  Invasive breast cancer: correlation of dynamic MR features with prognostic factors.

Authors:  Botond K Szabó; Peter Aspelin; Maria Kristoffersen Wiberg; Tibor Tot; Beata Boné
Journal:  Eur Radiol       Date:  2003-07-26       Impact factor: 5.315

Review 10.  Gene expression profiling in breast cancer.

Authors:  Shannon R Morris; Lisa A Carey
Journal:  Curr Opin Oncol       Date:  2007-11       Impact factor: 3.645
View more
  4 in total

1.  Diagnosis of solid breast tumors using vessel analysis in three-dimensional power Doppler ultrasound images.

Authors:  Yan-Hao Huang; Jeon-Hor Chen; Yeun-Chung Chang; Chiun-Sheng Huang; Woo Kyung Moon; Wen-Jia Kuo; Kuan-Ju Lai; Ruey-Feng Chang
Journal:  J Digit Imaging       Date:  2013-08       Impact factor: 4.056

2.  Contribution of kinetic characteristics of axillary lymph nodes to the diagnosis in breast magnetic resonance imaging.

Authors:  Sebnem Orgüç; Işıl Başara; Gökhan Pekindil; Teoman Coşkun
Journal:  Balkan Med J       Date:  2012-09-01       Impact factor: 2.021

3.  The value of T2* in differentiating metastatic from benign axillary lymph nodes in patients with breast cancer--a preliminary in vivo study.

Authors:  Chuanming Li; Shan Meng; Xinhua Yang; Jian Wang; Jiani Hu
Journal:  PLoS One       Date:  2014-01-16       Impact factor: 3.240

4.  Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer.

Authors:  Meijie Liu; Ning Mao; Heng Ma; Jianjun Dong; Kun Zhang; Kaili Che; Shaofeng Duan; Xuexi Zhang; Yinghong Shi; Haizhu Xie
Journal:  Cancer Imaging       Date:  2020-09-15       Impact factor: 3.909
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.